• Xianpeng Xu, Tao Guo, Zifeng Liu, Peng Chen, Ying Zhang, Qingjie Ji, and Hui Xie.
• Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China.
• Patient Prefer Adher. 2022 Jan 1; 16: 2867-2876.

ObjectiveTo comprehensively summarize the evidence on the preferences, expectations, and values of hypertension management and treatment in hypertensive patients.MethodsFrom inception through January 2022, PubMed, Embase, Web of Science, EBSCO, and China National Knowledge Infrastructure were searched for studies with hypertension value, preference, or expectation. A qualitative retrospective analysis was performed.ResultsA total of 24 studies involving 8701 participants were included. Although studies on the preferences of hypertensive patients are difficult to standardize, considerable convergence has occurred: 1) Patients preferred treatment regimens with lower incidence of comorbidities, faster response, lower cost, more frequent blood pressure monitoring, fewer side effects, and more convenient medication. 2) Patients have a crucial role in the treatment, and their physicians are expected to develop a shared patient-centered decision-making model.ConclusionThe results of this systematic review demonstrated that side effects, cost, and convenience are important factors for patients when selecting a treatment regimen for hypertension. Patients often obtain hypertension information from their physicians and prefer shared patient-centered decision-making.© 2022 Xu et al.

4 keywords...

hide…